The small print on the j and j though is zero people in the trial got seriously ill or died which is a big deal. If it behaves like a cold when you get sick that’s going to be an acceptable criteria. Plus I don’t think the fda is that smart .I think they look at these processes as linear . I dont sense any innovative ideas or creativity coming from them to push a drug like Leronlimab over the finish line any quicker than the jnj vaccine